Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.82 USD | +6.23% | +9.33% | +11.56% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.56% | 20.85M | |
+14.07% | 109B | |
+0.87% | 30.23B | |
+11.79% | 22.34B | |
-12.02% | 18.66B | |
-9.28% | 16.99B | |
+16.49% | 16.24B | |
-5.43% | 12.07B | |
+1.05% | 10.99B | |
-15.91% | 8.36B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 : Acquires Drone Mapping Software Firm Identified Technologies